Surgical Metastasectomy in the Spine: A Review Article. (12th June 2021)
- Record Type:
- Journal Article
- Title:
- Surgical Metastasectomy in the Spine: A Review Article. (12th June 2021)
- Main Title:
- Surgical Metastasectomy in the Spine: A Review Article
- Authors:
- Kato, Satoshi
Demura, Satoru
Shinmura, Kazuya
Yokogawa, Noriaki
Shimizu, Takaki
Murakami, Hideki
Kawahara, Norio
Tomita, Katsuro
Tsuchiya, Hiroyuki - Abstract:
- Abstract: Background: The use of surgical metastasectomy (SM) has increased across cancer types in recent decades despite the increasing efficacy of modern systemic treatment modalities. Symptomatic spinal metastases severely compromise patients' performance status. However, as spinal SM is a complex surgery with potentially significant complications, it is not considered the treatment of choice. Methods: We reviewed the articles on SM in several primary cancers with different types of metastatic lesions and extracted the data from relevant articles to provide a comprehensive review including the surgical techniques, indications, reported outcomes, and future prospects of SM in spinal metastases. Results: Total en bloc spondylectomy (TES) is a method of spinal SM associated with a lower risk of tumor recurrence and complications. Intralesional transpedicular osteotomy using a fine threadwire saw allows prevention of spinal cord and nerve root injuries. Spinal SM is considered suitable for patients with controlled primary disease having no evidence of disseminated extraspinal metastases, a completely resectable solitary lesion in the spine, and adequate cardiopulmonary reserve to tolerate the surgery. Metastatic lesions from kidney and thyroid cancers have been reported as the best candidates for spinal SM. Although data about spinal SM are limited, the reported outcomes are favorable with acceptable local recurrence rates in long-term follow-up. Conclusion: In patients withAbstract: Background: The use of surgical metastasectomy (SM) has increased across cancer types in recent decades despite the increasing efficacy of modern systemic treatment modalities. Symptomatic spinal metastases severely compromise patients' performance status. However, as spinal SM is a complex surgery with potentially significant complications, it is not considered the treatment of choice. Methods: We reviewed the articles on SM in several primary cancers with different types of metastatic lesions and extracted the data from relevant articles to provide a comprehensive review including the surgical techniques, indications, reported outcomes, and future prospects of SM in spinal metastases. Results: Total en bloc spondylectomy (TES) is a method of spinal SM associated with a lower risk of tumor recurrence and complications. Intralesional transpedicular osteotomy using a fine threadwire saw allows prevention of spinal cord and nerve root injuries. Spinal SM is considered suitable for patients with controlled primary disease having no evidence of disseminated extraspinal metastases, a completely resectable solitary lesion in the spine, and adequate cardiopulmonary reserve to tolerate the surgery. Metastatic lesions from kidney and thyroid cancers have been reported as the best candidates for spinal SM. Although data about spinal SM are limited, the reported outcomes are favorable with acceptable local recurrence rates in long-term follow-up. Conclusion: In patients with isolated resectable spinal metastases, complete SM including TES is a useful option as it can improve function and survival. However, appropriate patient selection and surgical feasibility remain the most important aspects of management. Implications for Practice: Surgical metastasectomy for spinal metastases may be a potentially curative treatment option with a low risk of local recurrence and lead to prolonged long-term survival if appropriate patients are selected and if the surgery is carried out by experienced surgeons in high-volume centers. Abstract : This review focuses on surgical techniques for complete surgical metastasectomy of spinal metastatic lesions, the potential indications, and the published clinical outcomes, and discusses the future prospects. … (more)
- Is Part Of:
- Oncologist. Volume 26:Number 10(2021)
- Journal:
- Oncologist
- Issue:
- Volume 26:Number 10(2021)
- Issue Display:
- Volume 26, Issue 10 (2021)
- Year:
- 2021
- Volume:
- 26
- Issue:
- 10
- Issue Sort Value:
- 2021-0026-0010-0000
- Page Start:
- e1833
- Page End:
- e1843
- Publication Date:
- 2021-06-12
- Subjects:
- Metastasectomy -- Neoplasm metastasis -- Patient selection -- Spine -- Surgical oncology
Oncology -- Periodicals
Tumors -- Periodicals
Cancérologie -- Périodiques
Tumeurs -- Périodiques
Oncology
Tumors
Neoplasms
Electronic journals
Periodicals
Periodicals
616.994 - Journal URLs:
- https://academic.oup.com/oncolo ↗
https://theoncologist.onlinelibrary.wiley.com/journal/1549490x ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/onco.13840 ↗
- Languages:
- English
- ISSNs:
- 1083-7159
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6256.890000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20846.xml